These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 8601536)

  • 1. The immunological background to transplantation.
    Haeney M
    J Antimicrob Chemother; 1995 Oct; 36 Suppl B():1-9. PubMed ID: 8601536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histoincompatibility-associated differences in the phenotypes of murine cardiac allograft infiltrating T cells.
    Carlquist JF; Shelby J; Hammond EH; Greenwood JH; Anderson JL
    Immunology; 1994 May; 82(1):149-53. PubMed ID: 7913913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The alloresponse.
    Hernandez-Fuentes MP; Baker RJ; Lechler RI
    Rev Immunogenet; 1999; 1(3):282-96. PubMed ID: 11256420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal transplant immunology in the last 20 years: A revolution towards graft and patient survival improvement.
    Sá H; Leal R; Rosa MS
    Int Rev Immunol; 2017 May; 36(3):182-203. PubMed ID: 27682364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tolerogenic response: allorecognition pathways.
    Caballero A; Fernandez N; Lavado R; Bravo MJ; Miranda JM; Alonso A
    Transpl Immunol; 2006 Dec; 17(1):3-6. PubMed ID: 17157204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Lymphocytes in transplantation immunity--in the relation to HLA antigens].
    Takata H
    Hum Cell; 1988 Sep; 1(3):275-81. PubMed ID: 2979204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular definition of the transplantation antigens.
    Parham P
    FEBS J; 2018 Aug; 285(15):2728-2745. PubMed ID: 29673068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunobiology of rejection and adaptation.
    Trivedi HL
    Transplant Proc; 2007 Apr; 39(3):647-52. PubMed ID: 17445565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Limited T cell response to donor MHC peptides during allograft rejection. Implications for selective immune therapy in transplantation.
    Benichou G; Fedoseyeva E; Lehmann PV; Olson CA; Geysen HM; McMillan M; Sercarz EE
    J Immunol; 1994 Aug; 153(3):938-45. PubMed ID: 7517977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The alloimmune response and effector mechanisms of allograft rejection.
    Arakelov A; Lakkis FG
    Semin Nephrol; 2000 Mar; 20(2):95-102. PubMed ID: 10746853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Donor major histocompatibility complex (MHC) peptides are presented by recipient MHC molecules during graft rejection.
    Benichou G; Takizawa PA; Olson CA; McMillan M; Sercarz EE
    J Exp Med; 1992 Jan; 175(1):305-8. PubMed ID: 1730925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Donor CD8 cells prevent allogeneic marrow graft rejection in mice: potential implications for marrow transplantation in humans.
    Martin PJ
    J Exp Med; 1993 Aug; 178(2):703-12. PubMed ID: 8101864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 'Resistance' to unrelated, DLA-nonidentical canine marrow grafts is unrestricted by the major histocompatibility complex.
    Raff RF; Sandmaier BM; Graham T; Loughran TP; Pettinger M; Storb R
    Exp Hematol; 1994 Aug; 22(9):893-7. PubMed ID: 8062888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The replacement of graft endothelium by recipient-type cells conditions allograft rejection mediated by indirect pathway CD4+ T cells.
    Kapessidou Y; Habran C; Buonocore S; Flamand V; Barvais L; Goldman M; Braun MY
    Transplantation; 2006 Aug; 82(4):582-91. PubMed ID: 16958183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD4 T cells can reject major histocompatibility complex class I-incompatible skin grafts.
    Wise M; Zelenika D; Bemelman F; Latinne D; Bazin H; Cobbold S; Waldmann H
    Eur J Immunol; 1999 Jan; 29(1):156-67. PubMed ID: 9933097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transplantation immunology.
    Warvariv V; Inokuchi S; Esquivel CO
    Surg Technol Int; 1993 Oct; 2():147-53. PubMed ID: 25951556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Processed MHC class I alloantigen as the stimulus for CD4+ T-cell dependent antibody-mediated graft rejection.
    Bradley JA; Mowat AM; Bolton EM
    Immunol Today; 1992 Nov; 13(11):434-8. PubMed ID: 1362058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A rendezvous before rejection: where do T cells meet transplant antigens?
    Briscoe DM; Sayegh MH
    Nat Med; 2002 Mar; 8(3):220-2. PubMed ID: 11875489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of "indirect" recognition in initiating rejection of skin grafts from major histocompatibility complex class II-deficient mice.
    Auchincloss H; Lee R; Shea S; Markowitz JS; Grusby MJ; Glimcher LH
    Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3373-7. PubMed ID: 8475083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The replacement of graft endothelium by recipient-type cells conditions allograft rejection mediated by indirect pathway CD4(+) T cells.
    Kapessidou Y; Habran C; Buonocore S; Flamand V; Barvais L; Goldman M; Braun MY
    Transplantation; 2006 Mar; 81(5):726-35. PubMed ID: 16534475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.